Literature DB >> 16863767

Elective surgery for thoracic aortic aneurysms: late functional status and quality of life.

Andreas Zierer1, Spencer J Melby, Jordon G Lubahn, Gregorio A Sicard, Ralph J Damiano, Marc R Moon.   

Abstract

BACKGROUND: Elective surgical treatment for thoracic aortic aneurysms is unique in that it is often performed on asymptomatic patients. Although it has been found to improve survival, the impact of elective surgery on late functional status and quality of life have yet to be examined.
METHODS: Over a 5-year period, 110 asymptomatic patients underwent elective thoracic aortic replacement for ascending, descending, or thoracoabdominal aneurysms. Mean age was 67 +/- 9 years (53 > or = 70 years). Functional status, physical and psychological quality of life (Medical Outcome Study 36-Item Short Form Health Survey, in which 50 represents normalized age-matched US population), and survival (Kaplan-Meier) were assessed.
RESULTS: Return to normal activity level was independent of age (p > 0.59) and procedure (p > 0.18). At 35 +/- 20 months, psychological quality of life was similar between surgical groups (p > 0.71), but physical quality of life was lower after thoracoabdominal versus ascending or descending aneurysms (p < 0.02). Age did not impact physical quality of life (40 +/- 13 > or = 70 years versus 42 +/- 11 < 70 years, p > 0.58), but older patients had improved psychological quality of life (52 +/- 9 > or = 70 years versus 47 +/- 8 < 70 years, p > 0.03). Overall survival was 79% +/- 4% at 2 years and 70% +/- 5% at 4 years, but was lower with thoracoabdominal versus ascending or descending aneurysms (p < 0.002). Multivariate analysis identified thoracoabdominal (p < 0.004), advanced age (p < 0.03), chronic renal failure (p < 0.03), and congestive heart failure (p < 0.001) as predictors of late death.
CONCLUSIONS: Advanced age did not impair return to normal functional status, and older patients had improved psychological quality of life. Survival and physical quality of life were lowest with thoracoabdominal versus ascending or descending aneurysms. Thus, patients with asymptomatic thoracic aneurysms should not be denied elective replacement based on age alone, as functional recovery was not significantly impaired.

Entities:  

Mesh:

Year:  2006        PMID: 16863767     DOI: 10.1016/j.athoracsur.2006.03.042

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Health-Related Quality of Life in Thoracic Aortic Disease: Part I. Cases Managed Non-operatively.

Authors:  Christian Olsson; Anders Franco-Cereceda
Journal:  Aorta (Stamford)       Date:  2013-08-01

Review 2.  Wrapping of the ascending aorta revisited-is there any role left for conservative treatment of ascending aortic aneurysm?

Authors:  José María González-Santos; María Elena Arnáiz-García
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

3.  Indications for replacement of the thoracic aorta.

Authors:  Mario Costillo-Sang; Marc Moon
Journal:  Mo Med       Date:  2012 Jul-Aug

4.  Short-term Outcomes of Aortic Wrapping for Mild to Moderate Ascending Aorta Dilatation in Patients Undergoing Cardiac Surgery.

Authors:  Ji Young Park; Je-Kyoun Shin; Jin Woo Chung; Jun Seok Kim; Hyun Keun Chee; Meong-Gun Song
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-06-07

5.  Neurologic outcomes from high risk descending thoracic and thoracoabdominal aortic operations in the era of endovascular repair.

Authors:  Steven R Messé; Joseph E Bavaria; Michael Mullen; Albert T Cheung; Rebecca Davis; John G Augoustides; Jacob Gutsche; Edward Y Woo; Wilson Y Szeto; Alberto Pochettino; Y Joseph Woo; Scott E Kasner; Michael McGarvey
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

6.  Health-Related Quality of Life in Thoracic Aortic Disease: Part II. After Surgery on the Proximal (Root, Ascending, Arch) Aorta.

Authors:  Christian Olsson; Anders Franco-Cereceda
Journal:  Aorta (Stamford)       Date:  2013-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.